Description of the evolution of symptoms in the four groups in weeks 0 and 20.</p
Overview of patient characteristics and disease markers at time of hospitalisation.</p
Symptoms with overall prevalence increasing from baseline to 3 months and increasing or remaining hi...
Symptoms presence and the most common symptoms encountered during the acute phase of COVID-19.</p
<p>Showing a summary of the distribution of the 4 human syndromes under investigation.</p
<p>*: new signs of early neurological deterioration.</p><p>The nature of early neurological deterior...
<p>Comparison of clinical symptoms and co-morbidity status among the three patient groups.</p
<p>Symptoms and events in patients’ history of present illness, signs and laboratory findings at the...
Summary of chronic conditions grouping for self-reported conditions in the Canadian Longitudinal Stu...
<p>The appearance of disease symptoms with time on leaves of a diseased plant.</p
Description of the four dengue transmission profiles that emerged from the cluster analysis of the d...
<p>Suspected Malaria Episodes (Experienced in the Past 4 Weeks) by Age, Region and SES.</p
Different phases of symptom development in tobacco used for race determination.</p
Summary of findings showing how the four themes relate to each other and the categories within each ...
<p>Mentions of individual symptoms in reports by timeslot (6a), total symptom reports of a given typ...
<p>Duration of Symptoms in osteomyelitis (OM) and vaso-occlusive crisis (VOC) groups.</p
Overview of patient characteristics and disease markers at time of hospitalisation.</p
Symptoms with overall prevalence increasing from baseline to 3 months and increasing or remaining hi...
Symptoms presence and the most common symptoms encountered during the acute phase of COVID-19.</p
<p>Showing a summary of the distribution of the 4 human syndromes under investigation.</p
<p>*: new signs of early neurological deterioration.</p><p>The nature of early neurological deterior...
<p>Comparison of clinical symptoms and co-morbidity status among the three patient groups.</p
<p>Symptoms and events in patients’ history of present illness, signs and laboratory findings at the...
Summary of chronic conditions grouping for self-reported conditions in the Canadian Longitudinal Stu...
<p>The appearance of disease symptoms with time on leaves of a diseased plant.</p
Description of the four dengue transmission profiles that emerged from the cluster analysis of the d...
<p>Suspected Malaria Episodes (Experienced in the Past 4 Weeks) by Age, Region and SES.</p
Different phases of symptom development in tobacco used for race determination.</p
Summary of findings showing how the four themes relate to each other and the categories within each ...
<p>Mentions of individual symptoms in reports by timeslot (6a), total symptom reports of a given typ...
<p>Duration of Symptoms in osteomyelitis (OM) and vaso-occlusive crisis (VOC) groups.</p
Overview of patient characteristics and disease markers at time of hospitalisation.</p
Symptoms with overall prevalence increasing from baseline to 3 months and increasing or remaining hi...
Symptoms presence and the most common symptoms encountered during the acute phase of COVID-19.</p
DOI
Add to ORKG